Cipher Pharma (CPHR) Said Considering Sale - Reuters

October 31, 2016 11:21 AM EDT
Get Alerts CPHR Hot Sheet
Trade CPHR Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.


Cipher Pharma (NASDAQ: CPHR) has hired an investment bank to review strategic alternatives, including a potential sale, according to Reuters, citing people familiar with the matter.

The review comes amid increased scrutiny of specially drug prices, the report said.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk, Trading Halts

Add Your Comment